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Abstract
Background: To assess the retinal sensitivity in obstructive sleep apnea hypopnea syndrome (OSAHS) patients
evaluated with standard automated perimetry (SAP). And to correlate the functional SAP results with structural
parameters obtained with optical coherence tomography (OCT).
Methods: This prospective, observational, case-control study consisted of 63 eyes of 63 OSAHS patients (mean age
51.7 ± 12.7 years, best corrected visual acuity ≥20/25, refractive error less than three spherical or two cylindrical
diopters, and intraocular pressure < 21 mmHg) who were enrolled and compared with 38 eyes of 38 age-matched
controls. Peripapillary retinal nerve fiber layer (RNFL) thickness was measured by Stratus OCT and SAP sensitivities
and indices were explored with Humphrey Field Analyzer perimeter. Correlations between functional and structural
parameters were calculated, as well as the relationship between ophthalmologic and systemic indices in OSAHS
patients.
Results: OSAHS patients showed a significant reduction of the sensitivity for superior visual field division (p = 0.034,
t-student test). When dividing the OSAHS group in accordance with the severity of the disease, nasal peripapillary
RNFL thickness was significantly lower in severe OSAHS than that in controls and mild-moderate cases (p = 0.031
and p = 0.016 respectively, Mann-Whitney U test). There were no differences between groups for SAP parameters.
We found no correlation between structural and functional variables. The central visual field sensitivity of the SAP
revealed a poor Pearson correlation with the apnea-hipopnea index (0.284, p = 0.024).
Conclusions: Retinal sensitivity show minor differences between healthy subjects and OSAHS. Functional
deterioration in OSAHS patients is not easy to demonstrate with visual field examination.
Keywords: Visual field, Automated perimetry exam, Optical coherence tomography, Obstructive sleep apnea
syndrome, OSAHS
Background
Obstructive sleep apnea-hypopnea syndrome (OSAHS)
is a disorder characterized by brief episodes of complete
or partial upper airway collapse during sleep. When
those apnea-hypopnea events sum five or more events
per hour, a pathological breathing status appears. Nu-
merous ophthalmological disorders seem to be associ-
ated with OSAHS, including floppy-eyelid syndrome or
central serous chorioretinopathy. Moreover, some au-
thors suggest that certain optic nerve (ON) disorders
such as papilledema, glaucoma or non-arteritic anterior
ischemic optic neuropathy showed an increased inci-
dence in the obstructive disease [1–10].
Changes in the retinal nerve fiber layer (RNFL) thick-
ness have been reported in OSAHS by multiple authors.
These alterations appear even in individuals in whom
glaucomatous neuropathy has been ruled out, proposing
therefore the breathing disease could be “per se” an
aggressive agent for the ON [11–16].
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Studies describing the progression of the most common
neuropathy in our specialty, glaucomatous neuropathy,
have contributed to establish a relationship between the
functional visual impairment and the structural damage of
the ON [17, 18]. Other pathologies, as sclerosis multiple,
also seem to have a good agreement and correlation
between abnormalities detected by standard automated
perimetry (SAP) and RNFL measurements, as Cheng et
al. found in eyes with optic neuritis secondary to this
cause [19].
The aim of this study was to investigate whether there
is a visual field (VF) functional deficit in OSAHS pa-
tients compared to healthy individuals. And to study if
there is a correlation between functional variables and
structural (OCT) variables in OSAHS.
Methods
Eighty OSAHS patients were consecutively recruited in
the Otolaryngology Department at the Hospital Miguel
Servet, in Zaragoza, Spain. All patients had a newly dis-
covered and previously untreated mild to severe OSAHS
according to clinical features and apnea–hypopnea index
(AHI) greater than 4. Before OSAHS was confirmed, pa-
tients completed a questionnaire concerning epidemio-
logical data and information about symptoms such as
loud snoring, observed apnea, or excessive daytime sleepi-
ness. The most common vascular risk factors were studied
and treated if necessary.
Patients were subsequently referred for an ophthalmo-
logical examination to the Ophthalmology Department
at the Hospital Clínico Lozano Blesa in Zaragoza, Spain,
between December 2010 and March 2012. Patients with
history of stroke with central apnea, chronic uveitis,
antiglaucomatous drug usage, optic neuropathy, ocular
trauma or surgeries were excluded from this study. After
appropriate information, written informed consent of all
subjects was obtained. The research followed the tenets
of the Declaration of Helsinki, and the protocol was
approved by the local Ethics Committee.
The control group included 40 age-matched healthy sub-
jects, who were recruited among relatives and employees at
the Hospital Lozano Blesa. Selection was made with Berlin
questionnaire (evaluating the functional signs of OSAHS,
86% sensitivity for diagnosis and 77% specificity) [20, 21].
Epidemiological data were collected and smoking habit and
vascular risk factors were treated in the same way.
All OSAHS and controls underwent a complete oph-
thalmologic examination, including best-corrected visual
acuity (BCVA), ocular motility, slit-lamp biomicroscopy,
Goldmann applanation tonometry, gonioscopy, Humphrey
automated VF, and OCT examination. Values of the right
eyes were selected for analysis except when they did
not fulfill the inclusion criteria; in this case, left eyes
were selected.
At least two reliable SAP were performed to minimize
the learning effect. VFs were evaluated with a Humphrey
Field Analyzer perimeter model 740i (Zeiss Humphrey
Systems, Dublin, CA) by using the 24–2 SITA fast strat-
egy, with a Goldman size III stimulus on a 31.5-apostilb
background. Near addition was added to the subject’s
refractive correction. If fixation losses were higher than
20% or false positive or false-negative rates were higher
than 15%, the test was repeated. Each perimetry was per-
formed on different days to avoid the fatigue effect and
the same experienced examiner conducted all scans.
OCT was performed with the Stratus OCT (Carl Zeiss
Meditec, Dublin, CA, USA) following 1% tropicamide in-
stillation. Only high-quality images were included. Each
patient underwent scans to measure peripapillary RNFL
thickness, which was automatically calculated by the fast
RNFL algorithm. We considered the overall thickness and
per quadrant.
Examiners were masked to the diagnosis. All partici-
pants had a BCVA of 20/30 or better, with a refractive
error lower than three spherical or two cylindrical diop-
ters. Intraocular pressure (IOP) > 21 mmHg, posterior
segment pathology or patients with media opacification
were excluded. Regarding VF, eyes with defects compat-
ible with glaucoma (nasal step, paracentral or arcuate
scotomas, or arcuate blind spot enlargement) with a pat-
tern standard deviation (PSD) significantly elevated be-
yond the 5% level and/or a Glaucoma Hemifield Test
outside normal limits were also excluded.
For comparison we used Humphrey global indices
such as mean deviation (MD) and PSD, and we also
calculated mean sensitivity (MS) recording each of the
threshold values in decibel scale. Sector MD was calcu-
lated by averaging the deviation values on total-deviation
plots for each sector. To investigate correspondence be-
tween structure and function, we used a more simplified
version of the topographic map obtained by Garway-
Heath [17], proposed by Cheng et al. [19]. Nevertheless,
we introduced some subtle variations on Cheng’s map,
like the use of all sensitivity points, including the blind
spot ones (Fig. 1).
Statistical analysis
Data analysis was performed by using Statistical Package
for Social Sciences software (version 19.0, Chicago, IL,
USA). Values were presented as mean ± standard devi-
ation, and expressed in microns for the peripapillary
RNFL thickness and in decibels for the VF sensitivities.
Qualitative differences between the studied variables
were assessed by using Pearson’s chi-squared test.
Differences between controls and OSAHS were tested
by Student’s-t test when normality and equality of vari-
ances were proved. If these conditions were not satisfied,
the non-parametric Mann-Whitney U test was used.
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In a second analysis, OSAHS sample was divided ac-
cording to severity into two groups: those with mild-
moderate OSAHS (group 1, AHI ≥5 and < 30) and those
with severe OSAHS (group 2, AHI ≥30). Both groups were
compared to controls. Quantitative differences between
the three groups were compared by using one-way
ANOVA test, once normality and homogeneity was
proved with Shapiro-Wilk and Levene’s tests. In the event
of breach of the homogeneity and normality assumption,
the non-parametric Kruskal-Wallis H test was applied. In
those cases where differences had been statistically signifi-
cant, two by two Scheffé comparison (after ANOVA test)
or Mann-Whitney U analysis (after Kruskal-Wallis H test)
were performed to know which groups were different.
The relationship between structural and functional
variables were analyzed by applying linear, logarithmic,
inverse, quadratic and cubic models in OSAHS and in
controls separately. In addition, Pearson’s correlation co-
efficient between AHI and VF indices in OSAHS were
evaluated. A p value < 0.05 was considered statistically
significant.
Results
Of 80 consecutive OSAHS who accepted to participate,
63 patients (66.9%) were included in the study (51 right
eyes and 12 left eyes), whereas 36 patients (33.1%) were
excluded. Twenty-nine patients had a mild-moderate
OSAHS (46%), and the other 34 patients (54%) had a
severe disorder.
In the control group, 40 individuals classified as “low
risk subjects” by the Berlin questionnaire were exam-
ined. Two patients were excluded after exclusion criteria
application, and finally the group was composed of 37
right eyes and one left eye of 38 healthy subjects.
Age showed no statistically significant difference be-
tween groups, neither when dividing the OSAHS group
according to its severity. In OSAHS group, although more
men than women were enrolled, we did not consider this
difference because gender has no effect on RNFL thick-
ness as previously mentioned [22]. Body mass index was
not matched, and was higher in OSAHS than that in con-
trols (p < 0.001). Nevertheless, no significant differences in
vascular risk factors (hypertension, diabetes and dyslipid-
emia) and prevalence of smoking habit between cases and
controls were found.
Table 1 shows the results of IOP, peripapillary RNFL
thickness and VF parameters in controls and OSAHS.
Differences between groups were just found in the VF
superior division, sensitivity was higher in healthy sub-
jects than in OSAHS ones. MD showed results close to
the statistical significance.
Table 2 shows the results of IOP and peripapillary
RNFL thickness measurements by dividing OSAHS patients
according to severity. IOP showed no differences between
groups. Nasal quadrant of peripapillary RNFL thickness
showed a difference between categories. Thus, nasal RNFL
thickness was significantly lower in severe OSAHS than that
in moderate OSAHS (p = 0.031, Mann-Whitney U test).
Moreover, nasal RNFL thickness was thinner in severe
OSAHS versus controls (p = 0.016, Mann-Whitney U test).
Humphrey VF results showed no differences between
controls and severity of OSAHS groups (Table 3). VF
superior division showed a nonstatistical trend (0.08,
ANOVA test). This difference was not statistically
significant when we applied a multiple comparison test:
p = 0.11 in controls versus mild-moderates; p = 0.295 in
controls versus severes; and p = 0.834 in mild-moderates
versus severes (Scheffé post hoc test).
Fig. 1 Corresponding areas: visual field – optic nerve. a Cheng et al. map. Correlation between OCT RNFL quadrants and corresponding sectors
on SAP 24–2. b Topographical division on map of absolute retinal sensitivity used in our study, based on the topographic map proposed by
Cheng et al. Note the inclusion of the points corresponding to the blind spot in the central division average sensitivity calculations
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Table 2 Comparison of IOP and RNFL thickness measurements between controls, mild, moderate and severe OSAHS patients
Normality S-W Homogeneity Levene Test ANOVA/Kruskall W
Severity Average ± SD
[Min-Max]
p-value p-value F p-value
IOP Control (N = 38) 15.1 ± 2.1 [10–19] 0.222 0.22 0.73 0.48*
Mild-Moderate (N = 29) 15.6 ± 2.6 [11–22] 0.138
Severe (N = 34) 15.8 ± 3 [10–21] 0.135
Average RNFL Control (N = 38) 98.6 ± 10.9 [68.9–117.5] 0.617 0.78 2.13 0.12*
Mild-Moderate (N = 29) 101.8 ± 10.4 [82.2–125.3] 0.651
Severe (N = 34) 96.3 ± 10.1 [76–118] 0.684
RNFL superior quadrant Control (N = 38) 119.9 ± 19.3 [69–159] 0.914 0.13 0.58 0.56*
Mild-Moderate (N = 29) 124.5 ± 13.6 [85–160] 0.215
Severe (N = 34) 122 ± 18.4 [90–162] 0.695
RNFL nasal quadrant Control (N = 38) 80.1 ± 16.9 [52–126] 0.126 0.21 / 0.029†
Mild-Moderate (N = 29) 79.0 ± 17.0 [47–117] 0.533
Severe (N = 34) 71.3 ± 14.1 [49–115] 0.05
RNFL inferior quadrant Control (N = 38) 124.2 ± 13.7 [93–160] 0.829 0.07 1.92 0.15*
Mild-Moderate (N = 29) 128.1 ± 19.9 [91–166] 0.688
Severe (N = 34) 120.2 ± 13.9 [92–163] 0.398
RNFL temporal quadrant Control (N = 38) 70.2 ± 12.3 [47–93] 0.410 0.91 1.34 0.27*
Mild-Moderate (N = 29) 75.3 ± 12.6 [51–101] 0.910
Severe (N = 34) 71.6 ± 13.5 [45–100] 0.272
IOP intraocular pressure, RNFL retinal nerve fiber layer, S-W Shapiro-Wilk, Kruskall W Kruskall Wallis, N number of eyes
*ANOVA test
†Kruskal Wallis (p value < 0.05)
Table 1 Comparison of IOP, RNFL thickness and Humphrey VF parameters between controls and OSAHS patients
Variable CONTROLS (N = 38) OSAHS (N = 63) p-value
IOP 15.1 ± 2.1 [10–19] 15.7 ± 2.8 [10–22] 0.218*
Average RNFL 98.60 ± 10.95 [68.86–117.54] 98.79 ± 10.55 [76–125.33] 0.932*
RNFL superior
Quadrant
119.89 ± 19.32 [69–159] 123.17 ± 16.35 [85–162] 0.385*
RNFL nasal
Quadrant
80.08 ± 16.92 [52–126] 74.86† ± 15.86 [47–117] 0.128*
RNFL inferior
Quadrant
124.21 ± 13.71 [93–160] 123.84 ± 17.29 [91–166] 0.906*
RNFL temporal
Quadrant
70.24 ± 12.33 [47–93] 73.30 ± 13.14 [45–101] 0.241*
Average sensitivity 29.74 ± 1.31† [26.59–31.87] 29.3 ± 1.46 [23.9–32.03] 0.097†
VF superior division 30.05 ± 1.54 [27.04–32.91] 29.37 ± 1.56 [25.08–32.3] 0.034*
VF inferior division 31.13 ± 1.43† [27.28–32.91] 30.89 ± 1.37 [26.57–33.66] 0.211†
VF central division 27.59 ± 1.44 [23.28–31.14] 27.43 ± 1.83 [24–32.14] 0.406†
VF temporal división 30.19 ± 2.0 [25.67–33.33] 29.49† ± 2.75 [13–33] 0.145†
VFI 99.16† ± 0.85 [97–100] 98.97† ± 0.983 [96–100] 0.361†
MD 0.04 ± 1.13 [(− 2.78) – 1.79] −0.389 ± 1.2 [(− 3.75) – 1.65] 0.07*
PSD 1.52† ± 0.3 [0.96–2.64] 1.61† ± 0.67 [0.9–5.93] 0.955†
IOP intraocular pressure, RNFL retinal nerve fiber layer, VF visual field, VFI visual field index, MD mean deviation, PSD pattern standard deviation, N number of eyes
*T-student test (p value < 0.05). Normal distribution confirmed (Shapiro-Wilk)
†U Mann-Whitney test. No normal distribution confirmed (Shapiro-Wilk)
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A relationship between functional and structural ON
parameters in both, OSAHS and controls, was not
demonstrated. Table 4 shows linear, logarithmic, inverse,
quadratic and cubic correlation models between linear
parameters, as the thickness of peripapillary RNFL quad-
rants and parameters expressed in logarithmic scale such
as VF sensitivities.
Only the central VF sensitivity of the SAP revealed a
poor correlation with the AHI, with a Pearson’s correl-
ation coefficient of 0.284 (p = 0.024, Fig. 2).
Discussion
The low oxygen levels during sleep lead to the adrenergic
system activation, inflammation and procoagulant mecha-
nisms prompting to endothelial dysfunction, oxidative
stress and metabolic deregulation [23]. This vascular
phenomenon may compromise ON perfusion and oxygen-
ation, ultimately leading to optic neuropathy [24, 25].
Several authors, including our own group, have published
RNFL thickness variations in individuals with sleep apnea
[11–16], which could be a consequence of vascular and
gasometric alterations triggered by OSAHS.
Peripapillary RNFL thickness reflects neuronal axons,
and would allow quantification of ganglion cell axonal loss
[26]. Moreover, VF values estimates functional loss of the
whole visual pathway, from retina to cortex [27]. VF maps
show a correspondence with neuronal distribution of
RNFL in the ON head, as Garway et al. demonstrated
[17]. Therefore, theoretically, a correlation between OCT
and VF parameters could be found. If this correspondence
appears, both OCT and VF could be potentially used as
biomarkers for neuronal degeneration in OSAHS patients.
Sensitivity of superior VF division was significantly lower
in OSAHS patients than that in controls. This finding is
not consistent with a significant change of inferior peripa-
pillary RNFL thickness, which corresponds topographically
Table 3 Comparison of Humphrey visual field sensitivities and indices between controls, mild, moderate and severe OSAHS patients
Normality S-W Homogeneity Test Levene ANOVA / Kruskall W
Severity Average ± SD
[Min - Max]
p-value p-value F p-value
Average sensitivity (dB) Control (N = 38) 29.7 ± 1.3 [26.6–31.8] 0.04 0.61 / 0.2†
Mild- Moderate (N = 29) 29.1 ± 1.6 [23.9–31.1] 0.4
Severe (N = 34) 29.4 ± 1.3 [26.0–32] 0.61
VF superior division (dB) Control (N = 38) 30.1 ± 1.5 [27–32.9] 0.158 0.83 2.49 0.08*
Mild- Moderate (N = 29) 29.2 ± 1.6 [26.3–32.2] 0.7
Severe (N = 34) 29.5 ± 1.5 [25.1–32.3] 0.19
VF inferior division (dB) Control (N = 38) 31.1 ± 1.4 [27.3–33.3] 0.01 0.62 / 0.46†
Mild- Moderate (N = 29) 30.9 ± 1.3 [26.6–32.9] 0.008
Severe (N = 34) 30.9 ± 1.4 [27.6–33.7] 0.91
VF central division (dB) Control (N = 38) 27.6 ± 1.4 [23.3–31.1] 0.46 0.11 0.73 0.49*
Mild- Moderate (N = 29) 27.2 ± 1.6 [24.3–31.4] 0.49
Severe (N = 34) 27.6 ± 2.0 [24–32.1] 0.17
VF temporal division (dB) Control (N = 38) 30.2 ± 2 [25.7–33.3] 0.06 0.08 / 0.34†
Mild- Moderate (N = 29) 29.7 ± 1.9 [26.3–33] 0.03
Severe (N = 34) 29.8 ± 1.7 [25.3–33] 0.33
VFI (dB) Control (N = 38) 99.2 ± 0.8 [97–100] < 0.001 0.63 / 0.6†
Mild- Moderate (N = 29) 98.9 ± 1.0 [96–100] 0.001
Severe (N = 34) 99.0 ± 0.9 [97–100] < 0.001
MD (dB) Control (N = 38) 0.04 ± 1.1 [(−2.8) – 1.8] 0.08 0.92 1.66 0.19*
Mild- Moderate (N = 29) −0.4 ± 1.12 [(−2.5) – 1.6] 0.21
Severe (N = 34) −0.4 ± 1.2 [(−3.8) - 1.7] 0.44
PSD (dB) Control (N = 38) 1.5 ± 0.3 [0.9–2.6] 0.01 0.1 / 0.97†
Mild- Moderate (N = 29) 1.6 ± 0.9 [1.0–5.9] 0.002
Severe (N = 34) 1.6 ± 0.4 [0.9–2.8] < 0.001
VF visual field, VFI visual field index, MD mean deviation, PSD pattern standard deviation, S-W Shapiro-Wilk, Kruskall W Kruskall Wallis, N number of eyes
*ANOVA test
†Kruskal Wallis
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Table 4 Correlation models between structural and functional optic nerve variables in OSAHS patients
OSAHS (N = 63) CONTROLS (N = 38) OSAHS (N = 63) CONTROLS (N = 38)
Regression model R2 F Test (p-value) R2 F Test (p-value) R2 F Test (p-value) R2 F Test (p-value)
RNFL inferior quadrant (μm) – VF superior división (dB) RNFL Superior quadrant (μm) – VF inferior división (dB)
Lineal 0.042 0.106 0.04 0.226 0.054 0.068 0.002 0.777
Logarithmic 0.049 0.083 0.046 0.196 0.047 0.087 0.006 0.631
Inverse 0.054 0.066 0.052 0.169 0.04 0.117 0.014 0.484
Quadratic 0.076 0.095 0.067 0.294 0.071 0.11 0.054 0.376
Cubic 0.077 0.090 0.067 0.294 0.07 0.114 0.054 0.376
RNFL nasal quadrant (μm) - VF temporal división (dB) RNFL temporal quadrant (μm) - VF central división (dB)
Lineal 0.014 0.362 0.006 0.644 0.004 0.642 0.001 0.831
Logarithmic 0.008 0.48 0.01 0.547 0.005 0.580 0.003 0.76
Inverse 0.004 0.622 0.015 0.468 0.007 0.518 0.004 0.709
Quadratic 0.045 0.25 0.048 0.421 0.012 0.691 0.045 0.447
Cubic 0.055 0.339 0.05 0.62 0.012 0.691 0.052 0.393
Average RNFL (μm) – MD (dB) Average RNFL (μm) - Average sensitivity (dB)
Lineal 0.005 0,585 0.011 0.531 0.007 0.514 0.008 0.584
Logarithmic / / / / 0.008 0.489 0.01 0.557
Inverse 0.017 0.309 0.001 0.861 0.009 0.469 0.011 0.533
Quadratic 0.046 0.241 0.044 0.453 0.014 0.663 0.074 0.261
Cubic 0.061 0.291 0.046 0.658 0.014 0.66 0.075 0.255
RNFL Retinal nerve fiber layer, MD mean deviation, VF visual field. N number of eyes
Fig. 2 Pearson’s correlation coefficient (0.284, p = 0.024) between central VF sensitivity and AHI
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with superior VF division and would justify the functional
decline. Subtle edema secondary to vascular deregulation
and increase in cerebrospinal fluid pressure [13, 28, 29]
could explain the VF alterations found in our patients, and
the fact that reduction in sensitivity is not associated with a
decrease in RNFL thickness. As we previously suggested
[14], it is possible that analysing all ranges of OSAHS
severity together imply masking certain ON structural alter-
ations. Theoretically, a first stage of edema and inflamma-
tion in mild and intermediate stages of the respiratory
disease would precede an atrophy phase. We should, there-
fore, think that the biggest differences will be found in the
most serious cases, where the decline of the RNFL will be
triggered by longer exposure to hypoxia, and will be logical
find higher degrees of atrophy. This fact is reflected in nasal
quadrant RNFL thickness, where we found differences
between severe OSAHS and the other groups. Another
possible theory explaining the functional loss without struc-
tural alteration is the association of OSAHS with floppy
eyelid syndrome [30–32]. A fatigue-related ptosis could
reduce superior visual field acting as an artefact, as the ‘nor-
mal’ OCT inferior RNFL thickness confirms.
On the other hand, VF parameters showed no differ-
ences in the two by two comparisons between OSAHS
groups and controls. This result contrasts with those
obtained by other authors. Thus, Huseyinoglu et al. [13]
found higher PSD and lower MD values in OSAHS
patients comparing to controls. Xin et al. and Tsang et al.
[29, 33] found affected values of MD and PSD in OSAHS
comparing with controls. Nevertheless, they did not ex-
clude any case of glaucoma and that could generate a bias
in their results. Ferrandez et al. [34] found a generalized
decrease in retinal sensitivity without focal defects in
OSAHS. Furthermore, they reported changes in MD, PSD
and VFI values with worse scores in patients with apnea.
Disparities between their results and ours could be justi-
fied by different examination strategies used. We have
chosen a shorter VF strategy to explore the patients since
we know that “fatigue effect” could modify VF outcomes
[33, 35] and is more prevalent in OSAHS patients [36–
38], even when the SAP reliability criteria were kept
within normal limits. We could observe a considerable
difficulty to some OSAHS patients to maintain the con-
centration for 4 to 8 min for VF completion. Because of
this, we decided to perform SITA-fast strategies in the
present study, in spite of this shorter algorithm is known
to improve the mean defect and to be less precise com-
pared to SITA standard [39]. It is likely that hypersom-
nia, which is one of the crucial symptoms of the
disease, could act as a confounding factor during VF
examination, obtaining lower sensitivity rates compar-
ing to controls, especially in longer examinations.
Regarding structure-function analysis, the absence of a
common scale for both measurements, logarithmic on one
side (decibels) and decimal on the other one (microns or
percentages), makes it difficult to draw a parallel relationship
between both examinations. There is a controversy regard-
ing the type of association between structural and functional
variables. Thus, various publications assume a linear correl-
ation when both parameters are expressed in a linear scale,
and an exponential or curvilinear relationship when one of
the variables is linear whereas the other one is expressed in
a logarithmic scale [40, 41]. Conversely, other authors hardly
found any differences between structure-function correla-
tions when the latter was expressed in logarithmic or linear
scale [42, 43]. Based on this, our research analyses the asso-
ciation applying linear and non-linear models.
Special interest would have the correlation between
the nasal quadrant of RNFL thickness and temporal VF
division, since we found statistically significant differ-
ences for the structural parameter. Relationship between
RNFL thickness quantified with Stratus OCT and VF
MD was better fitted with second-order polynomials
than with a linear model in patients with glaucoma [41].
These regression models describe a curvilinear relation-
ship, suggesting that progression of VF loss, when it is
expressed in MD, increases during the course of the
disease. This idea is compatible with the concept of
“functional reserve”, i.e. there must be a significant
structural damage to bring up a functional representa-
tion of the same in the VF [19, 44–47]. Therefore, the
absence of correlation found in the present study may
be a consequence of the perimetric exclusion criteria, by
which all eyes with suggestive alterations of glaucomat-
ous neuropathy were excluded from the analysis.
One of the strengths of our study is that we just in-
cluded patients with normal IOP, normal gonioscopy,
and no perimetric evidence of glaucomatous neuropathy,
in order to assess a hypothetical reduction in retinal sen-
sitivity produced exclusively by the respiratory disorder.
In this way, we avoid biased results by the inclusion of
glaucomatous patients, whose incidence, as we have
already mentioned, is higher in patients suffering from
apnea [7–10]. The main limitation of our study include
the relatively small sample size, mainly when OSAHS
were divided according to severity. Groups with larger
number of patients could have shown some correlation
between variables or more consistent conclusions.
Conclusions
In conclusion, due to the lack of association between vari-
ables and no significant differences in VF variables when
dividing OSAHS patients, we cannot state that perimetry is
a useful diagnostic tool to demonstrate functional deterior-
ation in OSAHS. Moreover, future research should analyze
the results obtained in patients with OSAHS prior and after
effective treatment, to establish the real VF involvement in
the apneic disorder.
Casas et al. BMC Ophthalmology  (2018) 18:66 Page 7 of 9
Abbreviations
AHI: Apnea–hypopnea index; BCVA: Best-corrected visual acuity; MD: Mean
deviation; MS: Mean sensitivity; OCT: Optical coherence tomography;
ON: Optic nerve; OSAHS: Obstructive sleep apnea hypopnea syndrome;
PSD: Pattern standard deviation; RNFL: Retinal nerve fiber layer;
SAP: Standard automated perimetry; VF: Visual field
Acknowledgements
Not applicable
Funding
The authors certify that they have NO affiliations with or involvement in any
organization or entity with any financial interest (such as honoraria;
educational grants; participation in speakers’ bureaus; membership,
employment, consultancies, stock ownership, or other equity interest; and
expert testimony or patent-licensing arrangements), or non-financial interest
(such as personal or professional relationships, affiliations, knowledge or
beliefs) in the subject matter or materials discussed in this manuscript.
Availability of data and materials
The datasets generated and/or analysed during the current study are not
publicly available due to individual data protection but are available from
the corresponding author on reasonable request.
Authors’ contributions
PC acquired and analyzed the data. Moreover she wrote the main ideas of
the work. FJA helped with the data interpretation. Moreover, he edited the
final work. EV selected the OSAHS patients and acquired
othorrinolaringologic data. GTG acquired the data and helped write the
main ideas. MIA designed the work. JAC helped with the data interpretation.
Moreover, he edited the final work. We confirm that the manuscript has
been read and approved by all named authors.
Ethics approval and consent to participate
The research followed the tenets of the Declaration of Helsinki, and the
protocol was approved by the local Ethics Committee (Clinical Univeristary
Hospital Lozano Blesa, Zaragoza).
Written informed consent for ophthalmological exploration and prospective
data collection of all subjects was obtained at the ophthalmology
department visit by the clinician examiner.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Ophthalmology, Hospital Clínico Universitario “Lozano Blesa”,
San Juan Bosco 15, ES-50009 Zaragoza, Spain. 2Department of
Otolaryngology, Hospital Universitario “Miguel Servet”, Zaragoza, Spain.
3Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain.
Received: 9 May 2017 Accepted: 21 February 2018
References
1. Karger RA, White WA, Park WC, et al. Prevalence of floppy eyelid syndrome
in obstructive sleep apnea-hypopnea syndrome. Ophthalmology. 2006;113:
1669–74.
2. Leroux les Jardins G, Glacet-Bernard A, Lasry S, Housset B, Coscas G,
Soubrane G. Retinal vein occlusion and obstructive sleep apnea syndrome.
J Fr Ophtalmol. 2009;32:420–4.
3. Jain AK, Kaines A, Schwartz S. Bilateral central serous chorioretinopathy
resolving rapidly with treatment for obstructive sleep apnea. Graefes Arch
Clin Exp Ophthalmol. 2010;248:1037–9.
4. Kloos P, Laube I, Thoelen. Obstructive sleep apnea in patients with central
serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2008;246:1225–8.
5. Purvin VA, Kawasaki A, Yee RD. Papilledema and obstructive sleep apnea
syndrome. Arch Ophthalmol. 2000;118:1626–30.
6. Palombi K, Renard E, Levy P, et al. Non-arteritic anterior ischaemic optic
neuropathy is nearly systematically associated with obstructive sleep
apnoea. Br J Ophthalmol. 2006;90:879–82.
7. Mojon DS, Hess CW, Goldblum D, et al. High prevalence of glaucoma in
patients with sleep apnea syndrome. Ophthalmology. 1999;106:1009–12.
8. Mojon DS, Hess CW, Goldblum D, Böhnke M, Körner F, Mathis J. Primary
open-angle glaucoma is associated with sleep apnea syndrome.
Ophthalmologica. 2000;214:115–8.
9. Bendel RE, Kaplan J, Heckman M, Fredrickson PA, Lin SC. Prevalence of
glaucoma in patients with obstructive sleep apnoea—a cross-sectional
case-series. Eye (Lond). 2008;22:1105–9.
10. Faridi O, Park SC, Liebmann JM, Ritch R. Glaucoma and obstructive sleep
apnoea syndrome. Clin Exp Ophthalmol. 2012;40:408–19.
11. Lin PW, Friedman M, Lin HC, Chang HW, Pulver TM, Chin CH. Decreased
retinal nerve fiber layer thickness in patients with obstructive sleep apnea/
hypopnea syndrome. Graefes Arch Clin Exp Ophthalmol. 2011;249:585–93.
12. Sagiv O, Fishelson-Arev T, Buckman G, et al. Retinal nerve fiber layer
thickness measurements by optical coherence tomography in patients with
sleep apnea syndrome. Clin Exp Ophthalmol. 2014;42:132–8.
13. Huseyinoglu N, Ekinci M, Ozben S, Buyukuysal C, Kale MY, Sanivar HS. Optic
disc and retinal nerve fiber layer parameters as indicators of
neurodegenerative brain changes in patients with obstructive sleep apnea
syndrome. Sleep Breath. 2014;18:95–102.
14. Casas P, Ascaso FJ, Vicente E, Tejero-Garcés G, Adiego MI, Cristóbal JA.
Retinal and optic nerve evaluation by optical coherence tomography in
adults with obstructive sleep apnea-hypopnea syndrome (OSAHS). Graefes
Arch Clin Exp Ophthalmol. 2013;251:1625–34.
15. Shiba T, Takahashi M, Sato Y, et al. Relationship between severity of
obstructive sleep apnea syndrome and retinal nerve fiber layer thickness.
Am J Ophthalmol. 2014;157:1202–8.
16. Kargi SH, Altin R, Koksal M, et al. Retinal nerve fibre layer measurements are
reduced in patients with obstructive sleep apnoea syndrome. Eye (Lond).
2005;19:575–9.
17. Garway-Heath DF, Poinoosawmy D, Fitzke FW, Hitchings RA. Mapping the
visual field to the optic disc in normal tension glaucoma eyes.
Ophthalmology. 2000;107:1809–15.
18. Ferreras A, Pablo LE, Garway-Heath DF, Fogagnolo P, García-Feijoo J.
Mapping standard automated perimetry to the peripapillary retinal nerve
fiber layer in glaucoma. Invest Ophthalmol Vis Sci. 2008;49:3018–25.
19. Cheng H, Laron M, Schiffman JS, Tang RA, Frishman LJ. The relationship
between visual field and retinal nerve fiber layer measurements in patients
with multiple sclerosis. Invest Ophthalmol Vis Sci. 2007;48:5798–805.
20. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin
questionnaire to identify patients at risk for the sleep apnea syndrome. Ann
Intern Med. 1999;131:485–91.
21. Sharma SK, Sinha S, Banga A, Pandey RM, Handa KK. Validation of the
modified Berlin questionnaire to identify patients at risk for the obstructive
sleep apnoea syndrome. Indian J Med Res. 2006;124:281–90.
22. Bowd C, Zangwill LM, Blumenthal EZ, et al. Imaging of the optic disc and
retinal nerve fiber layer: effects of age, optic disc area, refractive error and
gender. J Opt Soc Am A Opt Image Sci Vis. 2002;19:197–207.
23. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and
cardiovascular disease: cross sectional results of the sleep heart health
study. Am J Respir Crit Care Med. 2001;163:19–25.
24. Anderson DR. Glaucoma, capillaries and pericytes. 1. Blood flow regulation.
Ophthalmologica. 1996;210:257–62.
25. Karakucuk S, Goktas S, Aksu M, et al. Ocular blood flow in patients with
obstructive sleep apnea syndrome (OSAS). Graefes Arch Clin Exp
Ophthalmol. 2008;246:129–34.
26. Budenz DL, Anderson DR, Varma R, et al. Determinants of normal retinal
nerve fiber layer thickness measured by Stratus OCT. Ophthalmology. 2007;
114:1046–52.
27. Xie K, Liu CY, Hasso AN, Crow RW. Visual field changes as an early indicator
of glioblastoma multiforme progression: two cases of functional vision
changes before MRI detection. Clin Ophthalmol. 2015;9:1041–7.
28. Bucci FA Jr, Krohel GB. Optic nerve swelling secondary to the obstructive
sleep apnea syndrome. Am J Ophthalmol. 1988;105:428–30.
Casas et al. BMC Ophthalmology  (2018) 18:66 Page 8 of 9
29. Xin C, Zhang W, Wang L, Yang D, Wang J. Changes of visual field and optic
nerve fiber layer in patients with OSAS. Sleep Breath. 2015;19:129–34.
30. McNab AA. The eye and sleep apnea. Sleep Med Rev. 2007;11:269–76.
31. West SD, Turnbull C. Eye disorders associated with obstructive sleep
apnoea. Curr Opin Pulm Med. 2016;22:595-601.
32. Leibovitch I, Selva D. Floppy eyelid syndrome: clinical features and the
association with obstructive sleep apnea. Sleep Med. 2006;7:117–22.
33. Tsang CS, Chong SL, Ho CK, Li MF. Moderate to severe obstructive sleep
apnoea patients is associated with a higher incidence of visual field defect.
Eye. 2006;20:38–42.
34. Ferrandez B, Ferreras A, Calvo P, et al. Retinal sensitivity is reduced in
patients with obstructive sleep apnea. Invest Ophthalmol Vis Sci. 2014;55:
7119–25.
35. Gonzalez de la Rosa M, Pareja A. Influence of the “fatigue effect” on the
mean deviation measurement in perimetry. Eur J Ophthalmol. 1997;7:29–34.
36. Jurádo-Gámez B, Guglielmi O, Gude-Sampedro F, Buela-Casal G. Effect of CPAP
therapy on job productivity and psychosocial occupational health in patients
with moderate to severe sleep apnea. Sleep Breath. 2015;19:1293–9.
37. Tippin J, Sparks J, Rizzo M. Visual vigilance in drivers with obstructive sleep
apnea. J Psychosom Res. 2009;67:143–51.
38. Bjornsdottir E, Keenan BT, Eysteinsdottir B, et al. Quality of life among
untreated sleep apnea patients compared with the general population and
changes after treatment with positive airway pressure. J Sleep Res. 2015;24:
328–38.
39. Saunders LJ, Russell RA, Crabb DP. Measurement precision in a series of
visual fields acquired by the standard and fast versions of the Swedish
interactive thresholding algorithm: analysis of large-scale data from clinics.
JAMA Ophthalmol. 2015;133:74–80.
40. Hood DC. Relating retinal nerve fiber thickness to behavioral sensitivity in
patients with glaucoma: application of a linear model. J Opt Soc Am A Opt
Image Sci Vis. 2007;24:1426–30.
41. Leung CK, Chong KK, Chan WM, et al. Comparative study of retinal nerve
fiber layer measurement by Stratus OCT and GDx VCC, II: structure/function
regression analysis in glaucoma. Invest Ophthalmol Vis Sci. 2005;46:3702–11.
42. Nilforushan N, Nassiri N, Moghimi S, et al. Structure-function relationships
between spectral-domain OCT and standard achromatic perimetry. Invest
Ophthalmol Vis Sci. 2012;53:2740–8.
43. Bowd C, Zangwill LM, Medeiros FA, et al. Structure-function relationships
using confocal scanning laser ophthalmoscopy, optical coherence
tomography, and scanning laser polarimetry. Invest Ophthalmol Vis Sci.
2006;47:2889–95.
44. Ajtony C, Balla Z, Somoskeoy S, Kovacs B. Relationship between visual field
sensitivity and retinal nerve fiber layer thickness as measured by optical
coherence tomography. Invest Ophthalmol Vis Sci. 2007;48:258–63.
45. Costello F, Coupland S, Hodge W, et al. Quantifying axonal loss after optic
neuritis with optical coherence tomography. Ann Neurol. 2006;59:963–9.
46. Nouri-Mahdavi K, Hoffman D, Tannenbaum DP, Law SK, Caprioli J.
Identifying early glaucoma with optical coherence tomography. Am J
Ophthalmol. 2004;137:228–35.
47. Bowd C, Weinreb RN, Williams JM, Zangwill LM. The retinal nerve fiber layer
thickness in ocular hypertensive, normal, and glaucomatous eyes with
optical coherence tomography. Arch Ophthalmol. 2000;118:22–6.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Casas et al. BMC Ophthalmology  (2018) 18:66 Page 9 of 9
